SpringWorks Therapeutics (SWTX, $46.69) was one of the top gainers this week, climbing to $46.69 per share. A.I.dvisor analyzed 914 stocks in the Biotechnology Industry over the last week and discovered that of them () trended up while of them () trended down.
a clinical-stage biopharmaceutical company, which focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer